Security key
230770109
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common stock
- Total 13F shares
- 4,280,014
- Total 13F value
- $18,146,545
- Share change
- +2,437,976
- Put/Call ratio
- 3.7%
- SEC-reported price per share
- $4.23
- Number of holders
- 33
- Value change
- +$10,361,899
- Number of buys
- 18
- Number of sells
- 9
- Shares outstanding
- 15,075,924
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
33
Top holders
10
CPIX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
CUMBERLAND PHARMACEUTICALS INC SEC filings
CUMBERLAND PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 230770109
Recent filing periods:
Ownership snapshot
Top reported holders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ikarian Capital, LLC
Disclosed value leader
Ikarian Capital, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G
13F
Lead comparable stake: 4.9%
13D/G row: Ikarian Capital, LLC
Showing 1-6 of 15 holder rows.
Quick read
Ikarian Capital, LLC leads the comparable SEC ownership view at 4.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Ikarian Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Ikarian Capital, LLC
4.9%
RENAISSANCE TECHNOLOGIES LLC
3.4%
VANGUARD GROUP INC
2.5%
DIMENSIONAL FUND ADVISORS LP
1.8%
ACADIAN ASSET MANAGEMENT LLC
1.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13D/G
|
4.9%
|
$3,545,020
730,932 shares
|
$0 | 31 Mar 2025 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
3.4%
|
$1,201,976
507,163 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.5%
|
$886,975
374,251 shares
|
— | 31 Dec 2024 |
| DIMENSIONAL FUND ADVISORS LP |
13F
Company
|
1.8%
|
$646,937
272,969 shares
|
— | 31 Dec 2024 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
1.2%
|
$444,000
188,164 shares
|
— | 31 Dec 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
1.2%
|
$436,447
184,155 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
33
Shares
4,280,014
Rows available
33
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
33
Q1 2025 holders
33
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend